National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
This grant supports discovery, preclinical development, and proof-of-concept testing of new candidate drugs, neurostimulation approaches, novel ligands, and circuit-engagement devices for mental disorders, substance use disorders, or alcohol use disorder. It funds projects that develop and validate drug or device targets, with strong encouragement for academia-industry partnerships.
Key facts
Update history